Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Download (PDF, 222KB)
December 3, 2019
/
Guidelines
,
News
Share
the Post
Related
Posts
Response from CEO, CHAI about the Quick Start program in November 2016
IAC a community group in Indonesia demanding national food and drugs authority to expedite registration process of DAA medicines in Indonesia
Flawed patents on hepatitis C drugs latest to be challenged in global push for access
Support letter for inclusion of Daclatasvir on 4th March, 2015.
Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016
Glecaprevir-Pibrentasvir Effective for Hepatitis C After Treatment Failure
Strategies to Secure Access to Generic HCV Medicines
Letter from Community in Asia and Eastern Europe to Global Fund Board for Financing Hep C Treatment
